Ordering
Available Variants10 mg
CHA.50687-10mg
Price
€87.20
Available – Dispatch in 14 days
50 mg
CHA.50687-50mg
Price
€352.80
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mg | CHA.50687-10mg | €87.20 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
50 mg | CHA.50687-50mg | €352.80 |
≥98% (HPLC), β-lactamase inhibitor, powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C7H10N3NaO6S |
|---|---|
| CAS Number | 1192491-61-4 |
| Molecular Weight | 287.23 |
| UNSPSC Code | 51111800 |
| NACRES | NA.21 |
| MDL number | MFCD28900719 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
| Storage condition | desiccated |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Avibactam sodium, with a CAS number of 1192491-61-4, is a synthetic beta-lactamase inhibitor used in combination with other antibiotics to treat various bacterial infections. Its mechanism of action involves the inhibition of beta-lactamase enzymes, which are responsible for the inactivation of beta-lactam antibiotics. By inhibiting these enzymes, avibactam sodium restores the efficacy of beta-lactam antibiotics against bacteria that have developed resistance. Avibactam sodium has been shown to be effective against a wide range of Gram-negative bacteria, including those that produce extended-spectrum beta-lactamases and carbapenemases. It is typically administered intravenously in combination with other antibiotics, such as ceftazidime, to treat complicated urinary tract infections and other serious bacterial infections. The use of avibactam sodium has been approved by regulatory agencies in several countries, including the United States and Europe.
